LADENBURG THALMANN FINANCIAL SERVICES INC. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 29 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2018$22,000
+37.5%
30,0000.0%0.00%
Q2 2018$16,0000.0%30,0000.0%0.00%
Q1 2018$16,000
-20.0%
30,0000.0%0.00%
Q4 2017$20,000
+17.6%
30,0000.0%0.00%
Q3 2017$17,000
-32.0%
30,0000.0%0.00%
Q2 2017$25,000
-39.0%
30,0000.0%0.00%
-100.0%
Q1 2017$41,00030,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Ion Asset Management Ltd. 4,035,008$1,796,0000.76%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 4,779,800$2,127,0000.04%
ANGELO GORDON & CO., L.P. 1,057,068$470,0000.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 4,000,000$1,780,000,0000.03%
Nine Chapters Capital Management LLC 21,300$9,0000.02%
FEDERATED HERMES, INC. 2,143,431$954,0000.00%
Harel Insurance Investments & Financial Services Ltd. 40,000$18,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$135,0000.00%
WEDBUSH SECURITIES INC 18,000$8,0000.00%
Spark Investment Management LLC 23,800$10,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders